Clinical Trial Update: A Efficacy and Safety Study of Anlotinib Hydrochloride Capsule Combined With Chemotherapy Versus Placebo Combined With Chemotherapy as First-line Treatment in Subjects With Advanced Non-squamous Cell Non-small Cell Lung Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating anlotinib hydrochloride in combination with chemotherapy versus placebo with chemotherapy as first-line treatment for advanced non-squa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-squamous Non-small Cell Lung Cancer

Drugs mentioned

• Anlotinib hydrochloride capsule (Anlotinib hydrochloride)

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Advanced Non-squamous Cell Non-small Cell Lung Cancer | Phase 3 | Status: UNKNOWN